| Gene symbol | WT1 | Synonyms | AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | WT1 transcription factor | ||||
| GTO ID | GTC0148 |
| Trial ID | NCT01621724 |
| Disease | Acute Myeloid Leukemia | Chronic Myeloid Leukemia |
| Altered gene | WT1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | WT1 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study |
| Year | 2012 |
| Country | United Kingdom |
| Company sponsor | Cell Medica Ltd |
| Other ID(s) | D-00272-CT2014001|2006-004950-25 |
| Vector information | |||||
|
|||||
| Cohort1: dose level 1 | |||||||||||||||||
|
|||||||||||||||||
| Cohort2: dose level 2 | |||||||||||||||||
|
|||||||||||||||||